Evidence map›Paper›PMID 40181592›Full record

ArticleMedical physics2025

Point-cloud segmentation with in-silico data augmentation for prostate cancer treatment.

Jianxin Zhou, Massimiliano Salvatori, Kadishe Fejza, Gregory M Hermann, Angela Di Fulvio

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianxin ZhouDepartment of Nuclear, Plasma, and Radiological Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Massimiliano SalvatoriIFC-National Research Council, Pisa, Italy.
Kadishe FejzaOSF HealthCare, Department of Radiation Oncology, Peoria, Illinois, USA.
Gregory M HermannOSF HealthCare, Department of Radiation Oncology, Peoria, Illinois, USA.
Angela Di FulvioDepartment of Nuclear, Plasma, and Radiological Engineering, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Funding

Cancer Center at Illinois and OSF HealthCare under the Breakthrough Engineering and Advanced Treatment (BEAT) of Cancer Research Initiative 12306Jump Arches endowment through the Health Care Engineering Systems Center 2021-2-P341
6 · The paper itself

Abstract

backgroundIn external x-ray radiation therapy, the administered dose distribution can deviate from the planned dose due to alterations in patient positioning, changes in intra-fraction anatomy, and the limited precision of the beam delivery system in spatial terms. Adaptive radiation therapy (ART) can potentially improve dose delivery accuracy by re-optimizing the treatment plan before each fraction, maximizing the dose to the target volume while minimizing exposure to surrounding radiosensitive organs. However, to effectively implement ART, the stages of the radiation therapy pipeline, including image acquisition, segmentation, physician directive generation, and treatment plan generation, must be optimized for maximum speed and accuracy to ensure feasibility prior to each treatment fraction. In this work, we focus on image segmentation. By reducing the segmentation computation time, one can reproduce the planning process for each session, enabling routine customization for individual patients, achieving safe dose escalation, better cancer control, and reduced risk of severe radiotoxicity. PURPOSE: The aim of this study is to develop a fast point-cloud-based segmentation model with novel in-silico-aided data augmentation and demonstrate it on pelvic computed tomography (CT) patient data used in prostate cancer (PCa) treatment. This model can be implemented during ART because it requires only a few seconds to perform organ segmentation.

methodsIn this study, a dataset of pelvic CT images was obtained from Order of St. Francis (OSF) Healthcare Hospital (Peoria, IL, USA), comprising 38 images in total. These were divided into 25 for training, seven for validation, and six for testing the developed model. A novel point-cloud-based model was used to reduce the prostate segmentation time, cross-validation was implemented to ensure the robustness of the model. The developed point-cloud-based network is a novel deep-learning (DL) model that adds a loss function that combines region-based with a new boundary loss function. The region-based loss enables the identification of large volumes while the boundary loss, whose relative weight increases with the epochs, increases the network training ability of uneven surfaces, like the interface between the prostate bladder and rectum, which are challenging to resolve. We introduced a new data-augmentation approach to expand the training set. This fully automated method generates synthetic 3-D CT images by creating relevant organs in the extended cardiac-torso (XCAT) computational phantom. The Dice similarity coefficient was used as an assessment metric and compared to state-of-the-art segmentation models. The doses to the prostate and organs at risk (i.e., bladder and rectum) were also calculated for both our automated segmentation and manual expert segmentation to evaluate the practical feasibility of the point-cloud-based approach.

resultsOur model achieves the segmentation results (Dice coefficient) of 0.92

conclusionsOur proposed method demonstrates favorable performance in the segmentation of X-ray CT data. Results confirmed that the point-cloud-model is faster than voxel-based segmentation algorithms while achieving comparable or better segmentation results. The segmentation approach can be integrated into ART workflow, ultimately reducing the workload of clinicians and radiologists.

Indexed as

Computer SimulationImage Processing, Computer-AssistedProstatic NeoplasmsHumansMaleRadiotherapy Planning, Computer-AssistedTomography, X-Ray Computedpoint cloudprostate segmentationtreatment planning

Identifiers

PMID40181592
PMCPMC12270999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.